Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

China flag China · Delayed Price · Currency is CNY
11.78
+0.05 (0.43%)
Mar 10, 2026, 3:00 PM CST
-7.54%
Market Cap 4.77B
Revenue (ttm) 1.74B
Net Income (ttm) 160.68M
Shares Out 404.74M
EPS (ttm) 0.40
PE Ratio 29.48
Forward PE n/a
Dividend 0.34 (2.90%)
Ex-Dividend Date Jun 26, 2025
Volume 1,930,000
Average Volume 2,784,796
Open 11.73
Previous Close 11.73
Day's Range 11.73 - 11.82
52-Week Range 11.43 - 14.32
Beta 0.83
RSI 44.94
Earnings Date Apr 18, 2026

About SHA:603439

Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonic, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. The company was founded in 1995 and is based in Anshun, China. [Read more]

Sector Healthcare
Founded 1995
Employees 2,852
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603439
Full Company Profile

Financial Performance

In 2024, SHA:603439's revenue was 2.14 billion, an increase of 31.16% compared to the previous year's 1.63 billion. Earnings were 274.03 million, a decrease of -6.38%.

Financial Statements

News

There is no news available yet.